CAMPNasdaq

Camp4 Therapeutics Corp

Pharmaceutical Preparations · DE · CIK 1736730

Camp4 Therapeutics develops RNA-targeting therapeutics to upregulate gene expression and restore protein levels for genetic diseases

red 8-K · 90d

$218M

Market cap

$4.37

Last close

-1.6%

+0.2%

216K

Volume

Price · last 40 sessions+13.2%

May 4L $3.86 · H $4.56Jun 30

Total filings

Jun 12, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance